• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测神经内分泌肿瘤患者预后的68Ga-DOTATOC PET/CT图像纹理分析

Texture Analysis of 68Ga-DOTATOC PET/CT Images for the Prediction of Outcome in Patients with Neuroendocrine Tumors.

作者信息

Pellegrino Sara, Panico Mariarosaria, Bologna Roberto, Morra Rocco, Servetto Alberto, Bianco Roberto, Del Vecchio Silvana, Fonti Rosa

机构信息

Department of Advanced Biomedical Sciences, University Federico II, 80131 Naples, Italy.

Institute of Biostructures and Bioimages, National Research Council, 80145 Naples, Italy.

出版信息

Biomedicines. 2025 May 23;13(6):1286. doi: 10.3390/biomedicines13061286.

DOI:10.3390/biomedicines13061286
PMID:40564005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12189759/
Abstract

: The aim of our study is to evaluate whether texture analysis of 68Ga-DOTATOC PET/CT images can predict clinical outcome in patients with neuroendocrine tumors (NET). : Forty-seven NET patients who had undergone 68Ga-DOTATOC PET/CT were studied. Primary tumors were localized in the gastroenteropancreatic (n = 35), bronchopulmonary (n = 8), and other (n = 4) districts. NET lesions were segmented using an automated contouring program and subjected to texture analysis, thus obtaining the conventional parameters SUVmax and SUVmean, volumetric parameters of the primary lesion, such as Receptor-Expressing Tumor Volume (RETV) and Total Lesion Receptor Expression (TLRE), volumetric parameters of the lesions in the whole-body, such as wbRETV and wbTLRE, and texture features such as Coefficient of Variation (CoV), HISTO Skewness, HISTO Kurtosis, HISTO Entropy-log, GLCM Entropy-log, GLCM Dissimilarity, and NGLDM Coarseness. Patients were subjected to a mean follow-up period of 17 months, and survival analysis was performed using the Kaplan-Meier method and log-rank tests. : Forty-seven primary lesions were analyzed. Survival analysis was performed, including clinical variables along with conventional, volumetric, and texture imaging features. At univariate analysis, overall survival (OS) was predicted by age ( = 0.0079), grading ( = 0.0130), SUVmax ( = 0.0017), SUVmean ( = 0.0011), CoV ( = 0.0037), HISTO Entropy-log ( = 0.0039), GLCM Entropy-log ( = 0.0044), and GLCM Dissimilarity ( = 0.0063). At multivariate analysis, only GLCM Entropy-log was retained in the model (χ = 7.7120, = 0.0055). Kaplan-Meier curves showed that patients with GLCM Entropy-log >1.28 had a significantly better OS than patients with GLCM Entropy-log ≤1.28 (χ = 10.6063, = 0.0011). : Texture analysis of 68Ga-DOTATOC PET/CT images, by revealing the heterogeneity of somatostatin receptor expression, can predict the clinical outcome of NET patients.

摘要

我们研究的目的是评估68Ga-DOTATOC PET/CT图像的纹理分析能否预测神经内分泌肿瘤(NET)患者的临床结局。对47例已接受68Ga-DOTATOC PET/CT检查的NET患者进行了研究。原发性肿瘤位于胃肠胰(n = 35)、支气管肺(n = 8)和其他(n = 4)区域。使用自动轮廓程序对NET病变进行分割并进行纹理分析,从而获得传统参数SUVmax和SUVmean、原发性病变的体积参数,如受体表达肿瘤体积(RETV)和总病变受体表达(TLRE)、全身病变的体积参数,如wbRETV和wbTLRE,以及纹理特征,如变异系数(CoV)、HISTO偏度、HISTO峰度、HISTO熵对数、GLCM熵对数、GLCM差异和NGLDM粗糙度。患者的平均随访期为17个月,并使用Kaplan-Meier方法和对数秩检验进行生存分析。对47个原发性病变进行了分析。进行了生存分析,包括临床变量以及传统、体积和纹理成像特征。单因素分析显示,总生存期(OS)可由年龄(P = 0.0079)、分级(P = 0.0130)、SUVmax(P = 0.0017)、SUVmean(P = 0.0011)、CoV(P = 0.0037)、HISTO熵对数(P = 0.0039)、GLCM熵对数(P = 0.0044)和GLCM差异(P = 0.0063)预测。多因素分析显示,模型中仅保留了GLCM熵对数(χ = 7.7120,P = 0.0055)。Kaplan-Meier曲线显示,GLCM熵对数>1.28的患者的OS明显优于GLCM熵对数≤1.28的患者(χ = 10.6063,P = 0.0011)。68Ga-DOTATOC PET/CT图像的纹理分析通过揭示生长抑素受体表达的异质性,可以预测NET患者的临床结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8017/12189759/87700e954af3/biomedicines-13-01286-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8017/12189759/1e14378e9cb0/biomedicines-13-01286-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8017/12189759/88a0115a0e31/biomedicines-13-01286-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8017/12189759/87700e954af3/biomedicines-13-01286-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8017/12189759/1e14378e9cb0/biomedicines-13-01286-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8017/12189759/88a0115a0e31/biomedicines-13-01286-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8017/12189759/87700e954af3/biomedicines-13-01286-g003.jpg

相似文献

1
Texture Analysis of 68Ga-DOTATOC PET/CT Images for the Prediction of Outcome in Patients with Neuroendocrine Tumors.用于预测神经内分泌肿瘤患者预后的68Ga-DOTATOC PET/CT图像纹理分析
Biomedicines. 2025 May 23;13(6):1286. doi: 10.3390/biomedicines13061286.
2
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
4
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
8
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Pretreatment F-FDG PET/CT in predicting the survival of patients with hepatic neuroendocrine tumors.治疗前F-FDG PET/CT对肝神经内分泌肿瘤患者生存情况的预测
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2025 Jun 20:500198. doi: 10.1016/j.remnie.2025.500198.

本文引用的文献

1
Inter- and intra-tumoral heterogeneity on [Ga]Ga-DOTA-TATE/[Ga]Ga-DOTA-TOC PET/CT predicts response to [Lu]Lu-DOTA-TATE PRRT in neuroendocrine tumor patients.[镓]Ga-DOTA-TATE/[镓]Ga-DOTA-TOC PET/CT上的肿瘤间和肿瘤内异质性可预测神经内分泌肿瘤患者对[镥]Lu-DOTA-TATE肽受体放射性核素治疗的反应。
EJNMMI Rep. 2024 Nov 30;8(1):39. doi: 10.1186/s41824-024-00227-3.
2
Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myeloma.18F-FDG PET/CT 图像变异系数和纹理分析预测多发性骨髓瘤患者的预后。
Ann Hematol. 2024 Sep;103(9):3713-3721. doi: 10.1007/s00277-024-05905-7. Epub 2024 Jul 24.
3
[Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study.
[吕]吕-DOTA-TATE 联合长效奥曲肽对比高剂量长效奥曲肽治疗新诊断的晚期 2-3 级、高分化胃肠胰神经内分泌肿瘤(NETTER-2):一项开放标签、随机、3 期研究。
Lancet. 2024 Jun 29;403(10446):2807-2817. doi: 10.1016/S0140-6736(24)00701-3. Epub 2024 Jun 5.
4
Preoperative assessment of lymph nodal metastases with [Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours.采用[Ga]Ga-DOTATOC PET 影像组学术前评估淋巴结转移,提高分化型胰腺神经内分泌肿瘤的手术规划。
Eur J Nucl Med Mol Imaging. 2024 Jul;51(9):2774-2783. doi: 10.1007/s00259-024-06730-w. Epub 2024 May 2.
5
Coefficient of Variation in Metastatic Lymph Nodes Determined by F-FDG PET/CT in Patients with Advanced NSCLC: Combination with Coefficient of Variation in Primary Tumors.F-FDG PET/CT测定的晚期非小细胞肺癌患者转移淋巴结的变异系数:与原发肿瘤变异系数的联合应用
Cancers (Basel). 2024 Jan 9;16(2):279. doi: 10.3390/cancers16020279.
6
Applications of Artificial Intelligence and Radiomics in Molecular Hybrid Imaging and Theragnostics for Neuro-Endocrine Neoplasms (NENs).人工智能与放射组学在神经内分泌肿瘤(NENs)分子杂交成像及诊疗中的应用
Life (Basel). 2023 Jul 28;13(8):1647. doi: 10.3390/life13081647.
7
Heterogeneity of Glycolytic Phenotype Determined by F-FDG PET/CT Using Coefficient of Variation in Patients with Advanced Non-Small Cell Lung Cancer.利用变异系数通过F-FDG PET/CT测定晚期非小细胞肺癌患者糖酵解表型的异质性
Diagnostics (Basel). 2023 Jul 22;13(14):2448. doi: 10.3390/diagnostics13142448.
8
Prognostic Implications of PET-Derived Tumor Volume and Uptake in Patients with Neuroendocrine Tumors.正电子发射断层扫描(PET)得出的肿瘤体积和摄取情况对神经内分泌肿瘤患者的预后影响
Cancers (Basel). 2023 Jul 12;15(14):3581. doi: 10.3390/cancers15143581.
9
SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors.SNMMI生长抑素受体PET程序标准/EANM神经内分泌肿瘤成像实践指南
J Nucl Med. 2023 Feb;64(2):204-210. doi: 10.2967/jnumed.122.264860.
10
Dual [Ga]DOTATATE and [F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score.多中心验证 NETPET 评分:转移性胃肠胰神经内分泌肿瘤患者的双[Ga]DOTATATE 和 [F]FDG PET/CT。
Br J Cancer. 2023 Feb;128(4):549-555. doi: 10.1038/s41416-022-02061-5. Epub 2022 Nov 25.